医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
6期
304
,共1页
拉莫三嗪%药物性多形红斑
拉莫三嗪%藥物性多形紅斑
랍막삼진%약물성다형홍반
lamotrigine%drug-induced erythema multiforme
本文报道1例拉莫三嗪片致重症药物性多形红斑.用药前,需必须综合衡量用药的得益与风险;用药中,需告知患者密切关注自身药物反应,特别皮肤系统;用药后,使用糖皮质激素抗过敏需密切关注患者的精神状态,以防诱发癫痫.
本文報道1例拉莫三嗪片緻重癥藥物性多形紅斑.用藥前,需必鬚綜閤衡量用藥的得益與風險;用藥中,需告知患者密切關註自身藥物反應,特彆皮膚繫統;用藥後,使用糖皮質激素抗過敏需密切關註患者的精神狀態,以防誘髮癲癇.
본문보도1례랍막삼진편치중증약물성다형홍반.용약전,수필수종합형량용약적득익여풍험;용약중,수고지환자밀절관주자신약물반응,특별피부계통;용약후,사용당피질격소항과민수밀절관주환자적정신상태,이방유발전간.
@@@@This paper reports one case of severe drug-induced erythema multiforme caused by lamotrigine. Benefit and risks must be integrated before treatment; Patients should be informed to pay close attention to drug reactions, particularly skin system; In order to reduce the incidence of epilepsy, patients used corticosteroids need to be pay close attention to the mental state.
